Stockscreener 앱 받기
1.35
6.30%
0.08
시간 외 거래:
1.37
0.02
+1.48%
전일 마감가:
$1.27
열려 있는:
$1.45
하루 거래량:
1.39M
Relative Volume:
2.51
시가총액:
$12.23M
수익:
$895.50K
순이익/손실:
$-26.30M
주가수익비율:
-0.0206
EPS:
-65.5728
순현금흐름:
$-23.84M
1주 성능:
+16.38%
1개월 성능:
+16.38%
6개월 성능:
-5.59%
1년 성능:
-73.37%
1일 변동 폭
$1.30
$1.50
1주일 범위
$1.08
$1.50
52주 변동 폭
$0.92
$8.20
Mainz Biomed N V Stock (MYNZ) Company Profile
MYNZ을(를) 다른 주식과 비교
| 주식 | 가격 | 시가총액 | 매출 | 순이익 | 현금흐름 | 주당 순 이익 |
|---|---|---|---|---|---|---|
MYNZ
Mainz Biomed N V
|
1.35 | 11.51M | 895.50K | -26.30M | -23.84M | -65.57 |
|
TMO
Thermo Fisher Scientific Inc
|
620.72 | 229.63B | 43.74B | 6.58B | 6.11B | 17.31 |
|
DHR
Danaher Corp
|
236.59 | 166.25B | 24.27B | 3.50B | 5.02B | 4.8589 |
|
IDXX
Idexx Laboratories Inc
|
706.83 | 54.48B | 4.17B | 1.03B | 940.22M | 12.61 |
|
A
Agilent Technologies Inc
|
147.60 | 40.52B | 6.95B | 1.30B | 1.15B | 4.5696 |
|
IQV
Iqvia Holdings Inc
|
240.53 | 39.95B | 15.90B | 1.28B | 2.21B | 7.2842 |
Mainz Biomed N V Stock (MYNZ) Upgrades & Downgrades
| 날짜 | 액션 | 분석자 | 등급 변경 |
|---|---|---|---|
| 2025-02-14 | 개시 | Maxim Group | Buy |
| 2024-11-25 | 다운그레이드 | H.C. Wainwright | Buy → Neutral |
| 2023-11-21 | 다운그레이드 | Cantor Fitzgerald | Overweight → Neutral |
| 2022-06-21 | 개시 | H.C. Wainwright | Buy |
Mainz Biomed N V 주식(MYNZ)의 최신 뉴스
Mainz Biomed Provides Review of 2025 Highlights - GlobeNewswire
Earnings Risk: Why analysts upgrade Pony AI Inc Depositary Receipt stock2025 Short Interest & Weekly Consistent Profit Watchlists - moha.gov.vn
Is Mainz Biomed NV a good long term investmentBullish Engulfing Patterns & Insights From Wall Street Professionals - earlytimes.in
Form 424B5 MAINZ BIOMED N.V. - StreetInsider
Mainz Biomed (NASDAQ:MYNZ) Upgraded by Wall Street Zen to Hold Rating - Defense World
Mainz Biomed (NASDAQ:MYNZ) Stock Price Up 2.7% – Still a Buy? - Defense World
Why retail investors favor Mainz Biomed N.V. stockSwing Trade & Fast Gaining Stock Strategy Reports - Улправда
Why Mainz Biomed N.V. (4TO) stock is a strong buy callJuly 2025 Trade Ideas & AI Driven Price Predictions - Улправда
How strong is Mainz Biomed N.V. stock revenue growthWeekly Trend Summary & Fast Gain Swing Alerts - Улправда
Why Mainz Biomed N.V. stock remains undervalued2025 EndofYear Setup & Risk Controlled Stock Pick Alerts - Улправда
Will Mainz Biomed N.V. stock reach all time highs in 20252025 Year in Review & Weekly Watchlist of Top Performers - Улправда
How Mainz Biomed N.V. stock reacts to inflationary pressuresJuly 2025 Sector Moves & Verified Momentum Watchlists - ulpravda.ru
Is Mainz Biomed N.V. stock a buy for dividend growthJuly 2025 Movers & Reliable Intraday Trade Alerts - Улправда
2 Small-Cap Biotechs That Could Reward Patient Investors - Investing.com
2 Small-Cap Biotechs That Could Reward Patient Investors - sharewise.com
12 Health Care Stocks Moving In Wednesday's After-Market Session - Benzinga
Is Mainz Biomed N.V. stock positioned for long term growthJuly 2025 News Drivers & AI Forecast Swing Trade Picks - Newser
Mainz Biomed (Nasdaq: MYNZ) targets $150M shelf to advance cancer diagnostics - Stock Titan
Why Mainz Biomed N.V. (4TO) stock attracts wealthy investorsWeekly Market Outlook & Stock Portfolio Risk Control - Newser
Can Mainz Biomed N.V. (4TO) stock sustain free cash flow2025 Top Gainers & Fast Moving Stock Trade Plans - Newser
Is Mainz Biomed N.V. (4TO) stock expanding market penetrationJuly 2025 News Drivers & AI Forecast Swing Trade Picks - Newser
DoctorBox Adds Mainz Biomed's ColoAlert to Its Portfolio - marketscreener.com
Why Mainz Biomed N.V. (4TO) stock is favored by hedge fundsProduct Launch & Weekly High Conviction Ideas - Newser
Mainz Biomed (MYNZ) Stock Analysis Report | Financials & Insights - Benzinga
DoctorBox Adds Mainz Biomed’s ColoAlert(R) to Its Portfolio - GlobeNewswire
DoctorBox Adds Mainz Biomed’s ColoAlert® to Its Portfolio - TradingView — Track All Markets
Weekly Trades: Why hedge funds are buying Mainz Biomed N.V. stockJobs Report & Reliable Price Breakout Alerts - moha.gov.vn
Mainz Biomed N.V (MYNZ) looking to reclaim success with recent performance - Setenews
Mainz Biomed launches up to $2.6M at-the-market stock sale - Stock Titan
Mainz Biomed (NASDAQ:MYNZ) Shares Down 5.8% – What’s Next? - Defense World
Will Mainz Biomed N.V. stock see insider buyingJuly 2025 Closing Moves & Daily Profit Maximizing Trade Tips - newser.com
Is Mainz Biomed N.V. stock positioned well for digital economy2025 Bull vs Bear & Reliable Price Breakout Signals - newser.com
Is Mainz Biomed N.V. (4TO) stock attractive for dividend growth - newser.com
What’s the recovery path for long term holders of Mainz Biomed N.V.Earnings Growth Report & Stepwise Swing Trade Plans - newser.com
Can Mainz Biomed N.V. stock continue upward trend2025 Biggest Moves & Trade Opportunity Analysis Reports - newser.com
What margin trends mean for Mainz Biomed N.V. stockJuly 2025 Reactions & Breakout Confirmation Trade Signals - newser.com
Is a relief rally coming for Mainz Biomed N.V. holdersInflation Watch & Verified Technical Signals - newser.com
Will Mainz Biomed N.V. outperform the marketBond Market & Short-Term Trading Opportunity Alerts - newser.com
How Mainz Biomed N.V. (4TO) stock performs in easing cycles - newser.com
Mainz Biomed N V (MYNZ) 재무 분석
매출
순이익
현금흐름
주당 순 이익
2.85%
자본화:
|
볼륨(24시간):